References
- Ablashi D.V., Chatlynne L.G., Whitman J.E. Jr, Cesarman E.: Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin. Microbiol. Rev. 15, 439–464 (2002)
- Achenbach C.J., Harrington R.D., Dhanireddy S., Crane H.M., Casper C., Kitahata M.M.: Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin. Infect. Dis. 54, 424–433 (2012)
- Adamczyk K., Byczkowska K., Kowalska-Piaskowska A., Mozer- -Lisewska I.: Zakażenia wywołane przez wirusy z rodziny Her- pesviridae u osób HIV dodatnich. Now. Lek.79, 474–478 (2010)
- Andersson J.: Epstein-Barr virus and Hodgkin’s lymphoma. Herpes, 13, 12–16 (2006)
- Aozasa K., Zaki MA.: Epidemiology and pathogenesis of nasal NK/T-cell lymphoma: a mini-review. ScientificWorld Journal. 11, 422–428 (2011)
- Bornkamm GW.: Epstein-Barr virus and the pathogenesis of Burkitt’s lymphoma: more questions than answers. Int. J. Cancer. 124, 1745–1755 (2009)
- Bower M., Nelson M., Young A.M., Thirlwell C., Newsom-Davis T., Mandalia S., Dhillon T., Holmes P., Gazzard B.G., Steb- bing J.: Immune reconstitution inflammatory syndrome associated with Kaposi’s sarcoma. J. Clin. Oncol. 23, 5224–5228 (2005)
- Braun-Falco O., Plewig G., Wolff H., Burgdorf W. (red.). Dermatology. Wyd. 2. Springer Verlag, Berlin-Heidelberg, 2000, s. 1486–1488
- Braz-Silva P.H., de Rezende N.P., Ortega K.L., de Macedo Santos R.T., de Magalhães M.H.: Detection of the Epstein-Barr virus (EBV) by in situ hybridization as definitive diagnosis of hairy leukoplakia. Head Neck Pathol.2, 19–24 (2008)
- Brinkmann M.M., Pietrek M., Dittrich-Breiholz O., Kracht M., Schulz T.F.: Modulation of host gene expression by the K15 protein of kaposi’s sarcoma-associated herpesvirus. J. Virol.81, 42–58 (2007)
- Campo E., Swerdlow S.H., Harris N.L., Pileri S., Stein H., Jaffe E.S.. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood, 117, 5019–5032 (2011)
- Carbone A., Gloghini A.: AIDS-related lymphomas: from pathogenesis to pathology. Br. J. Haematol. 130, 662–670 (2005)
- Carbone A., Gloghini A., Caruso A., De Paoli P., Dolcetti R.: The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis. Int. J. Cancer. 140, 1233–1245 (2017)
- Cattani P., Cerimele F., Porta D., Graffeo R., Ranno S., Marchetti S., Ricci R., Capodicasa N., Fuga L., Amico R., Cherchi G., Gazzilli M., Zanetti S., Fadda G.: Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin. Microbiol. Infect.9, 274–279 (2003)
- Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles DM.: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186–1191 (1995)
- Cesarman E., Mesri E.A.: Virus-associated lymphomas. Curr. Opin. Oncol.11, 322–332 (1999)
- Cesarman E.: Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett. 305, 163–174 (2011)
- Cesarman E.: Gammaherpesviruses and lymphoproliferative disorders. Annu. Rev. Pathol. 9, 349–372 (2014)
- Chaigne-Delalande B., Lenardo M.J. i wsp: Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science, 341, 186–191 (2013)
- Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles DM., Moore P.S.: Identification of herpesvirus-like DNA sequence in AIDS-associated KS. Science, 266, 1865–1869 (1994)
- Clavies A., Tiemann M., Wagner H-J., Dreger P., Suttorp M.: Epstein-Barr virus-associated post-transplant lymphoprolife- -rative disease after bone marrow transplantation mimicking graft-versus-host disease. Pediatr. Transplant. 4, 151–155 (2000)
- Connick E., Kane M.A., White I.E., Ryder J., Campbell T.B.: Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin. Infect. Dis. 39, 1852–1855 (2004)
- Cote TR, Manns A, Hardy CR i wsp.: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J. Natl. Cancer Inst.88, 675–679 (1996)
- Crane G.M., Ambinder R.F., Shirley C.M., Fishman E.K., Kasa- mon Y.L., Taube J.M., Borowitz M.J., Duffield A.S.: HHV-8-po- sitive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. Am. J. Surg. Pathol. 38, 426–432 (2014)
- Davi F., Raphaёl M. i wsp.: Burkitt-like lymphomas in AIDS patients: Characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin’s lymphomas. Burkitt’s Lymphoma Study Group. J. Clin. Oncol.16, 3788–3795 (1998)
- De Paoli P., Carbone A.: Kaposi’s Sarcoma Herpesvirus: twenty years after its discovery. Eur. Rev. Med. Pharmacol. Sci.20, 1288–1294 (2016)
- Dow D.E., Cunningham C.K., Buchanan A.M.: A Review of human herpesvirus 8, the Kaposi’s sarcoma-associated herpesvirus, in the pediatric population. J. Pediatric. Infect. Dis. Soc. 3, 66–76 (2014)
- Dupin N., Escande J.P. i wsp.: The influence of highly active antiretroviral therapy on AIDS-associated Kaposi’s sarcoma. Br. J. Dermatol.140, 875–881 (1999)
- Durandy A., Sutton L., Bordigoni P., Garnier J., Bidois J., Deist F., Blanche S., Fischer A.: Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood, 92, 3137–3147 (1998)
- Ebell M.H.: Epstein-Barr virus infectious mononucleosis. Am. Fam. Physician. 70, 1279–1287 (2004)
- Ensoli B., Barillari G., Salahuddin S.Z.: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients. Nature,345, 84–86 (1990)
- Emuss V., Lagos D., Pizzey A., Gratrix F., Henderson S.R., Boshoff C.: KSHV manipulates notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog. 5, e100016 (2009)
- Epstein M.A., Barr Y.M., Achong B.G.: A second virus-carrying tissue culture strain (EB2) of lymphoblasts from Burkitt’s lymphoma. Pathol. Biol. 12, 1233–1234 (1964)
- Epstein M.A., Henle G., Achong B.G., Barr Y.M.: Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma. J. Exp. Med.121, 761–770 (1965)
- Filipovich A.H., Zhang K., Snow A.L., Marsh R.A.: X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood,116, 3398–3408 (2010)
- Fujii T., Taguchi H., Katano H., Mori S., Nakamura T., Nojiri N., Nakajima K., Tadokoro K., Juji T., Iwamoto A.: Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan. J. Med. Virol.57, 159–162 (1999)
- Geng L., Wang X.: Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments. Int. J. Clin. Exp. Med. 8,14656–14671 (2015)
- Ghosh S., Bienemann K., Boztug K., Borkhardt A.: Interleu- kin-2-inducible T-cell kinase (ITK) deficiency – clinical and molecular aspects. J. Clin. Immunol. 34, 892–899 (2014)
- Görzer I., Niesters H.G., Cornelissen J.J., Puchhammer-Stöckl E.: Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res. 118, 105–114 (2006)
- Gramolelli S., Schulz TF.: The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J. Pathol. 235, 368–380 (2015)
- Grulich A.E., Vajdic C.M.: The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin. Oncol.42, 247–257 (2015)
- Hardie DR.: Human gamma-herpesviruses: a review of 2 divergent paths to oncogenesis. Transfus. Apher. Sci. 42, 177–183 (2014)
- zur Hausen H.: Epstein-Barr virus. (w) Infections Causing Human Cancer. Wiley-VCH Verlag, Weinhem, 2006, s. 65–95
- Hengge U., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., Seeber S.: Update on Kaposi’s sarcoma and other HHV-8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations and therapy. Lancet Infect. Dis.2, 281–292 (2002)
- Henke-Gendo C., Viejo-Borbolla A., Schulz T.F.: Kaposi’s sar- koma-associated herpesvirus (Human herpesvirus 8) (w) Principles and practice of clinical virology, red. A.J. Zuckerman, J.E. Banatvala, B.D. Schoub, P.D. Griffiths, P. Mortimer, Willey-Blackwell, Oxford, 2009, s. 245–261
- Heslop HE.: How I treat EBV lymphoproliferation. Blood, 114,4002–4008 (2009)
- Hladik W., Pellett P.E., Hancock J., Downing R., Gao H., Pac- kel L., Mimbe D., Nzaro E., Mermin J.: Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. J. Infect. Dis. 1206, 1497–1503 (2012)
- Jędrzejczak W.W.: Limfohistiocytoza hemofagocytarna – rzad- ko rozpoznawany uleczalny stan bezpośredniego zagrożenia życia występujący również u dorosłych. Acta Haematol. Pol. 38, 515–526 (2008)
- Kalinova L., Indrakova J., Bachleda P.: Post-transplant lymphoproliferative disorder. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 153, 251–257 (2009)
- Karst J., Konopka L.: Poprzeszczepowa choroba limfoprolifera- cyjna. Onkol. Pol. 8, 209–216 (2005)
- Kieff E., Rickinson A.B.: Epstein-Barr virus and its replication. (w) Fields Virology, wyd. 4, red. Fields B.N., Knipe D.M., Howley P. Philadelphia, PA: Lippincott Williams& Wilkins, 2001, s. 2511–2575
- Kim H.J., Huh J. i in.: Hematopathology Study Group of the Korean Society of Pathologists. Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification. J. Pathol. Transl. Med. 51, 352–358 (2017)
- Klein G.: Perspectives in studies of human tumor viruses. Front. Biosci.7, 268–274 (2002)
- Klepfish A., Zuckermann B., Schattner A.: Primary effusion lymphoma in the absence of HIV infection – clinical presentation and management. QJM. 108, 481–488 (2015)
- Kleynberg R.L., Schiller G.J.: Secondary hemophagocytic lym- phohistiocytosis in adults: an update on diagnosis and therapy. Clin. Adv. Hematol. Oncol. 10, 726–732 (2012)
- Knowles D.M., Inghirami G., Ubriaco A., Dalla-Favera R.: Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood. 73, 792–799 (1989)
- Kotlarek-Haus S., Haus O.: Chłoniaki u osób zakażonych HIV. Acta. Haematol. Pol. 31, 249–258 (2000)
- Larocca L.M., Gaidano G., i wsp.: The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histoge- netic derivation from germinal center-related B cells. Blood. 92, 1011–1019 (1998)
- Levine A.M., Tulpule A.: Clinical aspects and management of AIDS-related Kaposi’s sarcoma. Eur. J. Cancer. 37, 1288–1295 (2001)
- Li F.Y., Chaigne-Delalande B., Kanellopoulou C., Davis J.C., Matthews H.F., Douek D.C., Cohen J.I., Uzel G., Su H.C., Lenardo M.J.: Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature,475, 471–476 (2011)
- Liu M., Liu B., Liu B., Wang Q., Ding L., Xia C., Dong L.: Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases. Oncol. Rep.33, 1615– 1620 (2015)
- Luppi M., Barozzi P., Schulz T.F., Setti G., Staskus K., Trovato R., Narni F., Donelli A., Maiorana A., Marasca R., Sandrini S., Torelli G.: Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N. Engl. J. Med. 343, 1378–1385 (2000)
- Machaczka M.: Limfohistiocytoza hemofagocytarna – współ- czesny problem medyczny. Pol. Merk. Lek.187, 59–63 (2012)
- Machowicz R., Drozd-Sokołowska J., Zduńczyk D., Górnicka B., Boguradzki P., Jędrzejczak W.: Limfohistiocytoza hemofagocy- tarna (HLH) indukowana przez chłoniaka – opis przypadku. OncoReview,1, 304–307 (2011)
- Marsh R.A., Madden L., Kitchen B.J., Mody R., McClimon B., Jordan M.B., Bleesing J.J., Zhang K., Filipovich A.H.: XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood,116, 1079–1082 (2010)
- Martin D., Galisteo R., Molinolo A.A., Wetzker R., Hirsch E., Gutkind J.S.: PI3Kgamma mediates kaposi’s sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis. Cancer Cell,19, 805–813 (2011)
- Mckee P.H., Calonje E., Granter S.R.: Pathology of the skin with clinical correlations. Elsevier Mosby, London, 2006, s. 1830– 1836.
- Minhas V., Wood C.: Epidemiology and transmission of Kaposi’s sarcoma-associated herpesvirus. Viruses. 6, 4178–94 (2014)
- Mularoni A., Conaldi P.G. i wsp.: Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations with the Human Herpesvirus 8 miRNome and Specific T Cell Response. Am. J. Transplant. doi: 10.1111/ajt.14346 (2017)
- Münz C., Moormann A.: Immune escape by Epstein-Barr virus associated malignancies. Semin. Cancer. Biol. 18, 381–387 (2008)
- Mutlu A.D., Mesri E.A. i wsp.: In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced kaposi’s sarcoma. Cancer Cell,11, 245–258 (2007)
- Neparidze N., Lacy J.: Malignancies associated with Epstein-Barr virus: pathobiology, clinical features, and evolving treatments. Clin. Adv. Hematol. Oncol.12, 358–371 (2014)
- Newlon J.L., Couch M., Brennan J.: Castleman’s disease: three case reports and a review of the literature. Ear Nose Throat J. 86, 414–418 (2007)
- Oksenhendler E., Cazals-Hatem D., Schulz T.F., Barateau V., Grollet L., Sheldon J., Clauvel J.P., Sigaux F., Agbalika F.: Transient angiolymphoid hyperplasia and Kaposi’s sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N. Engl. J. Med.338, 1585–1590 (1998)
- Palac-Siczek M., Pierniczka-Załęska M., Borowska K.: Ograni- czona choroba Castlemana o łagodnym przebiegu klinicznym – opis przypadku. Otolaryngol. Pol.65, 108–111 (2011)
- Pierangeli A., Antonelli G., Gentile G.: Immunodeficiency-associated viral oncogenesis. Clin Microbiol Infect. 21, 975–983 (2015)
- Polizzotto M.N., Uldrick T.S., Hu D., Yarchoan R.: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. Front. Microbiol. 3, 73 (2012)
- Przybylski M., Dzieciatkowski T., Zduńczyk D., Jędrzejczak W.W., Luczak M.: Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report. Arch. Immunol. Ther. Exp. (Warsz).58, 247–252 (2010)
- Purtilo D.T., Cassel C.K., Yang J.P.S., Harper L.: X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet.1, 935–940 (1975)
- Purushothaman P., Dabral P., Gupta N., Sarkar R., Verma S.C.: KSHV genome replication and maintenance. Front. Microbiol. 7, 54 (2016)
- Ravell J., Chaigne-Delalande B., Lenardo M.: X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect. Curr. Opin. Pediatr. 26, 713–719 (2014)
- Reddy N., Rezvani K., Barrett A.J., Savani BN.: Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol. Blood Marrow Transplant. 17, 591–597 (2011)
- Lieberman P., Hu J., Renne R.: Gammaherpesvirus maintenance and replication during latency (w) Human Herpesviruses, Biology, Therapy and Immunoprophylaxis, red. Arvin A., Campa- delli-Fiume G., Mocarski E., Moore P.S., Roizman B., Whitley R., Yamanishi K., Cambridge University Press, Cambridge, 2007, s. 379–403
- Ruiz-Cordero R.R., Lewis J., Blieden C., Campuzano-Zuluaga G., Hernandez J., Lossos I.S., Ikpatt F., Chapman J.R., Vega F.: Unusual immunophenotypic variant of large B-cell lymphoma associated with HHV-8 and EBV in an HIV positive patient. Human Pathol.: Case Reports.2, 49–54 (2015)
- Sarmati L.: HHV-8 infection in African children. Herpes, 11, 2–8 (2004)
- Schulz T.: The pleiotropic effects of Kaposi’s sarcoma herpesvirus. J. Path.208, 187–198 (2006)
- Schwartzberg P.L., Mueller K.L., Qi H., Cannons J.L.: SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev. Immunol., 9, 39–46 (2009)
- Shu C.H., Chang Y.S., Liang C.L., Liu S.T., Lin C.Z., Chang P.: Distribution of type A and type B EBV in normal individuals and patients with head and neck carcinomas in Taiwan. J. Virol. Methods.38, 123–130 (1992)
- da Silva S.R., de Oliveira D.E.: HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett.305, 175–185 (2011)
- Simon K., Knysz B., Szybejko-Machaj G., Gładysz A: Mięsak Kaposiego u pacjentów z nabytym zespołem upośledzenia odporności (AIDS) — obserwacje własne. Współcz. Onkol. 1, 21–24 (2000)
- Sodhi A., Montaner S., Patel V., Gomez-Roman J.J., Li Y., Sausville E.A., Sawai E.T., Gutkind J.S.: AKT plays a central role in sarcomagenesis induced by kaposi’s sarcoma herpesvirus-encoded g protein-coupled receptor. Proc. Natl. Acad. Sci. USA, 101, 4821–4826 (2004)
- Soumerai J.D., Sohani A.R., Abramson J.S.: Diagnosis and management of Castleman disease. Cancer Control. 21, 266– 278 (2014)
- Stojanova J., Caillard S., Rousseau A., Marquet P.: Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants. Pharmacol. Res.63, 1–7 (2011)
- Sumazaki R., Kanegane H., Osaki M., Fukushima T., Tsu- chida M., Matsukura H., Shinozaki K., Kimura H., Matsui A., Miyawaki T.: SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses. Blood, 98, 1268–1270 (2001)
- Tappero J.W., Conant M.A., Wolf S.F., Berger T.G.: Kaposi’s sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J. Am. Acad. Dermatol. 28, 371–395 (1993)
- Thompson MP., Kurzrock R.: Epstein-Barr virus and cancer. Clin. Cancer Res. 10, 803–821 (2004)
- Thorley-Lawson D.A., Gross A.: Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350, 1328–1337 (2004)
- Tserenpuntsag B., Kołacińska A., Jabłonowska E.: Nowotwory związane z AIDS w erze skojarzonego leczenia antyretrowiru- sowego (HAART). Przegl. Epidemiol.61, 529–534 (2007)
- Uldrick T.S., Whitby D.: Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett. 305, 150–162 (2011)
- Vereide D., Sugden B.: Proof for EBV’s sustaining role in Burkitt’s lymphomas. Semin. Cancer Biol. 19, 389–393 (2009)
- Viejo-Borbolla A., Schulz T.F.: Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. AIDS Rev. 5, 222–229 (2003)
- Weiss L.M., Epstein-Barr virus and Hodgkin’s disease. Curr. Oncol. Rep. 2, 199–204 (2000)
- Zhang K., Wakefield E., Marsh R.: Lymphoproliferative Disease, X-Linked. 27.02.2004 [aktualizacja 30.06.2016]. (w) Pagon R.A., Adam M.P., Ardinger H.H. i in. (red.): Gene Reviews®[Internet], University of Washington, Seattle, (1993–2016)